Solid Biosciences Inc. (NASDAQ:SLDB) Receives $15.67 Consensus PT from Brokerages
Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) has been given an average rating of “Buy” by the twelve research firms that are covering the stock, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation and four have issued a strong buy recommendation on the company. The average twelve-month target […]
Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) has been given an average rating of “Buy” by the twelve research firms that are covering the stock, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation and four have issued a strong buy recommendation on the company. The average twelve-month target […]
